IL6 and metabolic syndrome: The pathophysiology of MetS is strongly linked to adipokine dysregulation, where excessive adipose tissue secretes pro-inflammatory cytokines such as tumour necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6), exacerbating insulin resistance and hypertension [19].